Clinical Expertise

Dr Vishakha Tripathi

Vishakha completed her undergraduate training and medicine and surgery through Manipal College of Medical Sciences and undertook her internship in Nepal. She came to the U.K. and commenced her further medical training with a focus on colorectal surgery. Following this, she ventured into special needs education and worked as a special needs teacher.

Vishakha then pursued two postgraduate qualifications and established her genetic counselling career with this knowledge base which she has been doing for 18 years.

She is a Consultant Genetic Counsellor at Guy’s & St Thomas’ and jointly leads the cancer genetics service including the cancer risk assessment service and the hereditary breast and ovarian cancer service. Her role has involved implementing the family history network within nursing and the embedded genetic counselling model within cancer care.

Vishakha is the Founder of DNA Connect and works closely with a team of clinical experts within genetic counselling and genetic medicine.

Qualifications:

Areas of expertise:

Charlotte Tomlinson

Charlotte completed her undergraduate training in Human Genetics through the University of Nottingham. Charlotte then pursued her postgraduate qualification and established her genetic counselling career with this knowledge base which she has been doing for 12 years.

She is a Consultant Genetic Counsellor at Guy’s & St Thomas’ and jointly leads the general genetics service including the Preimplantation Genetic Diagnosis service.

Her role has involved developing the first Klinefelter’s MDT clinic with a focus on fertility in the UK which has national and international interest.

Qualifications:

Areas of expertise:

Dr Anju Kulkarni

Dr Anju Kulkarni is a Consultant Clinical Geneticist at Guy’s and St Thomas’ NHS Foundation Trust. She provides private cancer genetics services at King Edward VII hospital and through HCA Healthcare UK, at London Bridge hospital, Leaders in Oncology Care and the Wellington hospital.

Anju graduated with distinctions in Medicine and Pathology from Imperial College School of Medicine in 2000 and subsequently trained at specialist level in both Medical Oncology, at University College London Hospital, and Clinical Genetics at Guy’s and St Thomas’ hospital, the Kennedy-Galton centre and the Royal Marsden hospital, before being appointed to her current NHS consultant post in 2012.

Anju is one of the few clinical geneticists in the UK to have trained at specialist level in both Medical Oncology and Clinical Genetics, giving her an in-depth knowledge of genomics and translational medicine within cancer care. She has led the development of multidisciplinary specialist clinics for BRCA1/2 gene mutation carriers and other rarer hereditary cancer conditions.

Anju has held several regional and national roles, including council member of the UK Cancer Genetics Group, medical advisor to the UK Genetic Counselling Registration Board and member of the Sarah Cannon Research Institutes’ Genomic Review Board. She has extensive clinical and academic experience in Cancer Genetics and has published, presented and taught on the topic at national and international level. Anju has a track record of establishing policies and guidelines relating to cancer genetics, by working with a broad range of colleagues across genetics and allied specialties.

She has been instrumental in the establishment of several digital transformation initiatives, including QGenome, an NHSE-funded app for healthcare professionals, and Nucleus, an online cancer genomics educational platform.

Qualifications:

Areas of expertise:

Dr Muriel Holder

Dr Muriel Holder is a Consultant Clinical Geneticist at Guy’s and St Thomas’ NHS Foundation Trust and Medway Maritime Hospital. She provides private clinical genetics services at the Portland hospital.

Muriel started working as an NHS consultant in clinical genetics at Guy's hospital in June 2012 and was head of service between 2020 and 2023. She previously trained and worked in clinical genetics at Lille University Hospital in France as a speciality registrar for four years and as a lecturer for six years. She graduated from Cochin university in Paris. She furthered her training at the Necker Hospital in Paris, as well as Great Ormond Street Hospital in London. She speaks French and English fluently.

Muriel has wide clinical and academic experience with a PhD and habilitation to supervise research in Clinical Genetics and has played a crucial role in more than 100 publications over the years. She teaches King’s College London’s students.

She is a Trustee for HF Mencap and has been heavily implicated at JED (a Franco-Belgian Charity) representing the scientific committee’s board for more than 15 years funding research projects in paediatric neurology and ophthalmology.

Her research interests are focused on limb differences, dysmorphology, dermatology and vascular diseases as well as fetal medicine and pre-implantation genetic testing. In light of this, she has set up a multidisciplinary monthly Clinic for patients with congenital limb differences at St Thomas’ Hospital.

Qualifications:

Areas of expertise:

Gail Norbury

Gail Norbury is a Consultant Clinical Scientist in Genetics at Guy’s and St Thomas’ NHS Foundation Trust. She routinely authorises molecular genetics reports for Synnovis, the Pathology Provider.

Gail graduated from University of Oxford in Biochemistry and subsequently trained as a Clinical Scientist in both Clinical Biochemistry and Genetics. She is a current Examiner in Genetics for the Royal College of Pathologists and Assessor for the Academy of Health Care Science.

Gail has held several professional roles over her career including being a member of the Royal College of Pathologists Council, Association of Clinical Genetics Quality Sub-Committee and NICE Diagnostic Advisory Group. She has been an appointed expert committee member for development of NICE guidance for Lynch Syndrome in both colorectal and endometrial cancer and for Familial Hypercholesterolaemia. She a currently a member of the NHSE Rare and Inherited Disease Genomic Test Evaluation Working Group.

Qualifications:

Areas of expertise:

Germline molecular testing, reporting and interpretation: